Zobrazeno 1 - 10
of 98
pro vyhledávání: '"William E, Wilkinson"'
Publikováno v:
Journal of Patient Safety. 7:213-223
OBJECTIVES Our aim for this study was to evaluate dialysis nurses' ability to detect and recover from nursing errors. METHODS Two clinical cases with a total of 12 embedded errors were constructed. The errors were based on real events but were modifi
Autor:
Witold Rużyłło, Peter R. Kowey, Edward L.C. Pritchett, Mikhail Y. Ruda, Richard L. Page, Stuart J. Connolly, Charles R. Kerr, William E. Wilkinson
Publikováno v:
The American Journal of Cardiology. 98:215-218
Azimilide hydrochloride (azimilide), an investigational antiarrhythmic drug, has shown variable efficacy in preventing atrial fibrillation (AF). This study was designed to assess its efficacy in maintaining sinus rhythm in patients with paroxysmal AF
Autor:
Charles R. Kerr, Richard L. Page, Edward L.C. Pritchett, Peter R. Kowey, Stuart J. Connolly, William E. Wilkinson
Publikováno v:
American Heart Journal. 151:1043-1049
Azimilide dihydrochloride (azimilide) is an investigational antiarrhythmic drug that has been tested in patients with a variety of arrhythmias. In patients with atrial fibrillation, it has shown excellent efficacy in some previous trials and minimal
Autor:
William E. Wilkinson, Linda L. Sanders, Dawn Provenzale, Paul C. Kuo, M. Heneghan, Andrew J. Muir
Publikováno v:
Liver Transplantation. 8:957-961
With the recent transition of the liver transplant allocation system to the Model for End-Stage Liver Disease, a major change is its reliance entirely on objective criteria. In previous reports, potential donor families and members of the transplant
Autor:
Stuart J. Connolly, William E. Wilkinson, Stephen R. Marcello, Edward L.C. Pritchett, Richard L. Page, Daniel J. Schnell
Publikováno v:
American Heart Journal. 143:643-649
Background Azimilide is a novel classification III antiarrhythmic agent that blocks both IKrand IKsand shows evidence of efficacy in patients with atrial fibrillation or flutter. Its effect on paroxysmal supraventricular tachycardia (PSVT) has not be
Autor:
William E. Wilkinson, Michael T. Brennan, David E. Kleiner, Bruce J. Baum, Rose Anne Leakan, Stanley R. Pillemer, Vidya Sankar, Jane C. Atkinson
Publikováno v:
Arthritis Care & Research. 47:189-195
Objective To investigate risk factors for positive minor salivary gland biopsy results in Sjogren's syndrome (SS) and dry mouth patients. Methods A total of 289 patients with dry mouth symptoms were evaluated. Potential risk factors for positive mino
Autor:
Stephen R. Marcello, Stuart J. Connolly, Daniel J. Schnell, Marcia C. Schulte, Edward L.C. Pritchett, Richard L. Page, William E. Wilkinson
Publikováno v:
Journal of Clinical Pharmacology. 42:388-394
The purpose of this study was to assess the effect of azimilide, a Class III antiarrhythmic drug, on ECG conduction intervals recorded during sinus rhythm in patients with a history of symptomatic atrial fibrillation or atrial flutter. In Phase I cli
Publikováno v:
Nephrology nursing journal : journal of the American Nephrology Nurses' Association. 41(1)
Experts are believed to make fewer errors than novices. Researchers in other domains have shown that experts not only make less errors, they also detect and recover from these errors better than non-experts. To investigate this phenomenon among dialy
Autor:
Stephen R. Marcello, Edward L.C. Pritchett, William E. Wilkinson, Richard L. Page, Stuart J. Connolly, Daniel J. Schnell
Publikováno v:
The American Journal of Cardiology. 88:974-979
We evaluated the efficacy and safety of azimilide, a new class III antiarrhythmic agent that blocks both the slow and fast components of the cardiac-delayed rectifier potassium currents in 4 randomized, double-blind, placebo-controlled trials with si
Publikováno v:
Journal of General Internal Medicine. 16:77-82
To determine if a visual intervention (medication grid) delivered to physicians can reduce medication regimen complexity.Nonrandomized, controlled trial.Veterans Affairs medical center.Eight hundred thirty-six patients taking at least 5 medications a